Analysts at Dahlman Rose maintain their "buy" rating on CF Industries Inc CF. The target price for CF is set to $100.
According to Dahlman Rose, “CF reported adjusted 2Q10 earnings of $2.51, missing our estimate and consensus of $3.25 and $2.97 respectively. The earnings miss was due partly to lower DAP sales volumes along with higher operational costs; however, the nitrogen segment reported better gross margins versus our expectation driven by better volume and prices. The balance of the underperformance was due to several below the line charges including: 1) higher D&A 2) higher interest costs, 3) higher tax rate, and 4) higher minority interest. Adjusted EBITDA of about $435MM met expectations driven mostly by better nitrogen volumes and pricing.”
“Management noted that they now expect Terra synergies to exceed their previous targeted range of $105MM-$135MM. We look for total synergies to range between $150MM-$175MM, including manufacturing efficiency gains and improving use of the KeyTrade relationship,” the analysts add.
More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in